Indications and Clinical Profile of Neonatal Admissions: A Cross-Sectional Descriptive Analysis from a Single Academic Center in Jordan

Figures & data

Table 1 Neonatal and Maternal Characteristics

Variables		N=1444	Percent
Gestational age (weeks)	<34	287	19.9
	34–36.6	545	37.7
	>37	612	42.4
Gender	Male	765	53
	Female	679	47
Birth weight (grams)	<1500	125	8.7
	1500–2500	568	39.3
	>2500	751	52
Source of admission	LD	1320	91.4
	NBN	12	0.8
	Out born	112	7.8
Mode of delivery	VD	519	36
	CS	925	64
Maternal age	˂21	36	2.5
	21–35	1069	74
	˃35	339	23.5
Parity	1	347	24
	≥2	1097	76
Assisted pregnancy	Yes	145	10
	No	1299	90
Pregnancy complications	GDM	96	6.6
	PET/PIH	74	5.1
	APH	22	1.5
	PROM	334	23.2
	Others	58	4

Abbreviations: LD, labor and delivery unit; NBN, normal newborn nursery; VD, vaginal delivery; CS, cesarean section; GDM, gestation diabetes mellitus; PET/PIH, preeclampsia or pregnancy-induced hypertension; APH, antepartum hemorrhage; PROM, prolonged rupture of membranes.

Table 2 Indications for NICU Admission

Indication	N=1444	Percent
Prematurity	482	33.4
Respiratory distress syndrome	418	28.9
Transient tachypnea of newborn	178	12.3
Prolonged rupture of membranes	304	21.1
Hyperbilirubinemia	154	10.7
Birth depression	78	5.4
Congenital anomalies	40	2.8
Suspected sepsis	18	1.2
Meconium aspiration syndrome	17	1.2
Hypoglycemia	14	1
Birth injury	3	0.2
Arrhythmia	1	0.1
Others	22	1.5

Table 3 Complications and Morbidities of Neonatal Admissions

Variables		Preterm		Term		P value
		N=832	Percent	N=612	Percent
Intraventricular hemorrhage	Grade 1–2	45	5.4	5	0.8	˂ 0.05
	Grade 3–4	7	0.8	0	0
	PVL	25	3	1	0.2
Retinopathy of prematurity	Stage 1–2	9	1.1	1	0.2	˂ 0.05
	Stage ≥3	9	1.1	1	0.2
Hypoxic ischemic encephalopathy		6	0.7	20	3.2	˂ 0.05
Respiratory distress syndrome		418	50.2	52	8.5	˂ 0.05
Surfactant doses	1	152	18.3	21	3.4	˂ 0.05
	≥2	92	11.1	4	0.7
Pneumothorax		20	2.4	3	0.5	˂ 0.05
Pulmonary hemorrhage		9	1.1	0	0.0	˂ 0.05
Pulmonary hypertension		30	3.6	11	1.8	˂ 0.05
BPD	Mild	19	2.3	3	0.5	˂ 0.05
	Moderate	13	1.6	0	0.0
	Severe	6	0.7	0	0.0
Respiratory support	IMV	178	21.4	39	6.4	˂ 0.05
	CPAP	500	60.1	155	25.3
Central lines	UAC/UVC	84	10.1	12	2.0	˂ 0.05
	PICC	16	1.9	1	0.2
	Central	1	0.1	5	0.8
Sepsis		45	5.4	14	2.3	˂ 0.05
Hyperbilirubinemia	Phototherapy	266	32	153	25	0.08
	IVIG	10	1.2	30	4.9
	Exchange Tx	3	0.4	9	1.5
Feeding	Breastmilk	18	2.2	46	7.5	0.15
	Formula	716	86.1	527	86.1
	Mixed	10	1.2	10	1.6
IV nutrition ≥ 72 hours	Dextrose	456	54.8	253	41.3	˂ 0.05
	PPN	163	19.6	16	2.6
Necrotizing enterocolitis	Total	12	1.4	1	0.2	˂ 0.05
	Surgery	3	0.4	1	0.2
Congenital anomalies	All	9	1.2	31	5	˂ 0.05
	GI	8	1.0	12	2	0.14
PRBC Transfusion	1	78	9.4	16	2.6	˂ 0.05
	>2	42	5.0	6	1
Thrombocytopenia		133	16.0	44	7.2	˂ 0.05

Abbreviations: PVL, periventricular leukomalacia; BPD, bronchopulmonary dysplasia; IMV, invasive mechanical ventilation; CPAP, continuous positive airway pressure; UAC, umbilical arterial catheter; UVC, umbilical venous catheter; PICC, peripherally inserted central catheter; IV, intravenous; IVIG, intravenous immunoglobulin.

Table 4 Discharge Outcomes

Variables		Preterm (n = 832)	Term (n = 612)	P value
		N(%) or Mean (SD)	N(%) or Mean (SD)
Disposition	Home	774 (93%)	606 (99%)	˂ 0.05 ᴬ
	Death	51 (6.1%)	4 (0.7%)
	Transfer	7 (0.9%)	2 (0.3%)
Discharge weight (grams)		2192 (841)	3108 (516)	˂ 0.05
Length of stay (days)		12.5 (15.9)	5.3 (9.6)	˂ 0.05
Corrected GA (weeks)		35.6 (2.5)	39.2 (2.5)	˂ 0.05

Notes: ᴬAdjusted OR: 9.9, 95% C.I: 3.5, 27.6.